article thumbnail

STAT+: Former Sage executives join biotech VC Cure Ventures

STAT

The two men worked together from 2013 until 2022, when Jonas left to start a biotech incubator with funding from investment giant CBC Group. The VC firm has hired Jeff Jonas, Sage’s former chief executive, and Al Robichaud, Sage’s former chief scientific officer, as partners, the team told STAT exclusively.

article thumbnail

How does HTA for orphan drugs differ across Europe?

pharmaphorum

The study reviewed all 80 European Medicines Agency (EMA) authorised drugs receiving an orphan designation between 1 January 2013 and 31 December 2019, analysing their HTA outcomes and time to reimbursement across France, Germany, England and Scotland. Rates of approval. A more favourable outcome from the German regulator took on average 1.4

Labelling 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mounjaro interactions to avoid

The Checkup by Singlecare

Drug interactions | Food interactions | Other interactions | Avoiding interactions | When to see a doctor Mounjaro (tirzepatide) is gaining popularity as a treatment for Type 2 diabetes mellitus and off-label for weight management. Now that you know some of the specific interactions, you are better prepared for the discussion.

article thumbnail

Smartphone-powered trial backs J&J’s Invokana for heart failure

pharmaphorum

Updated labelling for Invokana has already been approved to include data showing that it can reduce the risk of hospitalisation for heart failure and diabetic kidney disease in patients with type 2 diabetes, based on the CREDENCE trial. . billion in 2016 before the product was linked to an increased risk of lower limb amputation.

Labelling 105
article thumbnail

Full spectrum cannabidiol reduces anxiety and improves cognition

Hospital Pharmacy Europe

containing all the components in the plant) solution, has been found to significantly reduce anxiety levels but it also appeared to improve scores on several cognitive-related tests according to the findings in a small, open-label study by US researchers. A 2013 systematic review estimated that globally, anxiety disorders affect 7.3%

article thumbnail

AbbVie files Vraylar as add-on therapy for depression in US

pharmaphorum

The drug was originally rejected for schizophrenia and bipolar by the FDA back in 2013 with a request for more clinical data, finally getting a green light two years later, and it then failed a phase 3 study in depression in 2016. Vraylar is now one of AbbVie’s fastest-growing products with sales expected to reach around $2.2

article thumbnail

Red 40 side effects and how to avoid them

The Checkup by Singlecare

Red Dye 40 is among the most commonly used artificial food dyes in the United States, and you might see it labeled under a different name on the products you consume. Regardless of what manufacturers label it as, there have been ties to specific negative side effects when ingested too frequently. 40 Aluminum Lake, and FD&C Red No.